The mammary gland: basic structure and molecular signaling during development

SK Biswas, S Banerjee, GW Baker, CY Kuo… - International Journal of …, 2022 - mdpi.com
The mammary gland is a compound, branched tubuloalveolar structure and a major
characteristic of mammals. The mammary gland has evolved from epidermal apocrine …

[HTML][HTML] Stem cells and the differentiation hierarchy in mammary gland development

NY Fu, E Nolan, GJ Lindeman… - Physiological …, 2020 - journals.physiology.org
The mammary gland is a highly dynamic organ that undergoes profound changes within its
epithelium during puberty and the reproductive cycle. These changes are fueled by …

Early dissemination seeds metastasis in breast cancer

H Hosseini, MMS Obradović, M Hoffmann, KL Harper… - Nature, 2016 - nature.com
Accumulating data suggest that metastatic dissemination often occurs early during tumour
formation, but the mechanisms of early metastatic spread have not yet been addressed …

Mammary stem cells and the differentiation hierarchy: current status and perspectives

JE Visvader, J Stingl - Genes & development, 2014 - genesdev.cshlp.org
The mammary epithelium is highly responsive to local and systemic signals, which
orchestrate morphogenesis of the ductal tree during puberty and pregnancy. Based on …

Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer

JJ Kim, T Kurita, SE Bulun - Endocrine reviews, 2013 - academic.oup.com
Progesterone receptor (PR) mediates the actions of the ovarian steroid progesterone, which
together with estradiol regulates gonadotropin secretion, prepares the endometrium for …

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

E Lim, F Vaillant, D Wu, NC Forrest, B Pal, AH Hart… - Nature medicine, 2009 - nature.com
Basal-like breast cancers arising in women carrying mutations in the BRCA1 gene,
encoding the tumor suppressor protein BRCA1, are thought to develop from the mammary …

Prognostic markers in triple‐negative breast cancer

EA Rakha, ME El‐Sayed, AR Green, AHS Lee… - Cancer, 2007 - Wiley Online Library
BACKGROUND. Triple‐negative breast cancer (estrogen receptor‐negative, progesterone
receptor‐negative, and HER2‐negative) is a high risk breast cancer that lacks the benefit of …

Molecular definition of breast tumor heterogeneity

M Shipitsin, LL Campbell, P Argani, S Weremowicz… - Cancer cell, 2007 - cell.com
Cells with distinct phenotypes including stem-cell-like properties have been proposed to
exist in normal human mammary epithelium and breast carcinomas, but their detailed …

[HTML][HTML] Breast cancer: origins and evolution

K Polyak - The Journal of clinical investigation, 2007 - Am Soc Clin Investig
Breast cancer is not a single disease, but rather is composed of distinct subtypes associated
with different clinical outcomes. Understanding this heterogeneity is key for the development …

Triple-negative breast cancer: therapeutic options

S Cleator, W Heller, RC Coombes - The lancet oncology, 2007 - thelancet.com
Triple-negative breast cancers are defined by a lack of expression of oestrogen,
progesterone, and ERBB2 receptors. This subgroup accounts for 15% of all types of breast …